Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect (Q28196412)

13

Jean-François Bergmann

0 references

Aida Habib

8

Aïda Habib

0 references

Alain Cohen-Solal

4

Alain Cohen-Solal

0 references

Jean-Jacques Mourad

Jean-Jacques Mourad

3

1 reference

ORCID Public Data File 2021

Christophe Meune

1

Christophe Meune

0 references

Isabelle Mahé

2

Isabelle Mahé

0 references

Guy Simoneau

11

Guy Simoneau

0 references

author name string

Bernard Levy

5

0 references

Jean-Philippe Kevorkian

6

0 references

Guillaume Jondeau

7

0 references

Marilyne Lebret

9

0 references

Anne-Laure Knellwolf

10

0 references

Charles Caulin

European Journal of Heart Failure

12

0 references

language of work or name

English

0 references

publication date

June 2003

0 references

published in

0 references

volume

5

0 references

issue

3

0 references

page(s)

271-9

0 references

cites work

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Is aspirin safe for patients with heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Impact of aortic stiffness on survival in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Statistical methods for assessing agreement between two methods of clinical measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Arterial wave reflection in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Interaction between angiotensin-converting enzyme inhibitors and aspirin: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Combining salicylate and enalapril in patients with coronary artery disease and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Effect of combined aspirin and angiotensin-converting enzyme inhibitor therapy versus angiotensin-converting enzyme inhibitor therapy alone on readmission rates in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Even low-dose aspirin inhibits arachidonic acid-induced vasodilation in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Effect of aspirin and ifetroban on skeletal muscle blood flow in patients with congestive heart failure treated with Enalapril. Ifetroban Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: results of a double-blind, randomized comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Enzyme immunoassay measurement of the urinary metabolites of thromboxane A2 and prostacyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Enzyme immunoassays of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate using acetylcholinesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Wave reflection in the systemic circulation and its implications in ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Arterial wave reflections and survival in end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Vasodilatation to arachidonic acid in humans. An insight into endogenous prostanoids and effects of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

The aspirin-angiotensin-converting enzyme inhibitor tradeoff: to halve and halve not

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

The LIDO, HOPE, MOXCON and WASH studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0

Aortic input impedance in heart failure: comparison with normal subjects and its changes during vasodilator therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900006-0